A Study to Evaluate the Safety and Tolerability of Raxibacumab in Healthy Subjects
This study has been completed.
Sponsor:
Human Genome Sciences Inc., a GSK Company
Information provided by (Responsible Party):
GlaxoSmithKline ( Human Genome Sciences Inc., a GSK Company )
ClinicalTrials.gov Identifier:
NCT00639678
First received: March 13, 2008
Last updated: October 29, 2012
Last verified: October 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | September 2008 |
| Primary Completion Date: | July 2008 (Final data collection date for primary outcome measure) |
| Certification or Request for Extension to Delay Results Received: | October 14, 2009 |